Duration Capital

QuAD Subscription

Duration Capital publishes the research behind its strategies as a subscription. Two tiers, one engine: the QuAD Model's directional outlook for US interest rates, and a premium tier that adds standardized trade risk management levels. Enrollment is open to anyone at the posted price, on identical terms for every subscriber.

Subscriptions

Two tiers

Both tiers are built on the Quantitative Active Duration model — the same framework, grounded in 80 years of market data, that drives every Duration Capital strategy. The difference is what you receive: QuAD delivers the directional rate outlook; QuAD Premium adds the risk management levels for implementing it.

Tier One
QuAD
The QuAD Model's directional outlook for US interest rates.
What you receive
  • The QuAD Model's directional outlook for US rates — the same signal engine behind Duration Capital's strategies.
  • A composite view built from the model's five variable composites: economic activity, inflation, Fed policy, valuation, and technicals.
  • Published to every subscriber on identical terms.
Subscribe
Full Access Tier Two
QuAD Premium
Everything in QuAD, plus a standardized trade risk management overlay.
What you receive
  • Everything in the QuAD tier.
  • Optimized stop-loss and profit-taking levels for the published outlook.
  • Trade implementation matrix by active risk parameter.
Subscribe

Ready to subscribe?

Contact us to start a subscription, or with any question about either tier.

Contact Us

Duration Capital research subscriptions are impersonal research publications made available to the general public at the posted price, on identical terms for every subscriber. They are not tailored to the investment objectives, financial situation, or needs of any individual subscriber, and nothing in them is individualized investment, legal, tax, or accounting advice or a recommendation with respect to any subscriber's account. Duration Capital does not direct or manage subscriber accounts.

Trading futures and other financial instruments involves substantial risk of loss and is not suitable for all investors. Subscribers are solely responsible for their own investment decisions, including whether and how to act on any published research.